APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-device Clinical Decision Support Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-device Clinical Decision Support Software Market Analysis and Forecast 2026-2032

2 May 2026236 pages

Choose your research edition.

Industry ResearchNon-device Clinical Decision Support Software Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-device Clinical Decision Support Software Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Non-device Clinical Decision Support Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-device Clinical Decision Support Software Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-device Clinical Decision Support Software Market Analysis and Forecast 2026-2032236 pages · $4,950 USD

Market perspective

The global Non-device Clinical Decision Support Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Non-device Clinical Decision Support Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-device Clinical Decision Support Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-device Clinical Decision Support Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-device Clinical Decision Support Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Non-device Clinical Decision Support Software include Roche, Claricode, Philips Healthcare, Persivia, Cerner, Zynx Health, Elsevier, Epic and EPSi/Allscripts, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Non-device Clinical Decision Support Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-device Clinical Decision Support Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Non-device Clinical Decision Support Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-device Clinical Decision Support Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-device Clinical Decision Support Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Non-device Clinical Decision Support Software revenue, projected growth trends, production technology, application and end-user industry.

Non-device Clinical Decision Support Software Segment by Company

Roche

Claricode

Philips Healthcare

Persivia

Cerner

Zynx Health

Elsevier

Epic

EPSi/Allscripts

Stanson Health

Cambio

Premier

Truven/IBM

NDSC/Change

MEDITECH

Non-device Clinical Decision Support Software Segment by Type

On-premises

Cloud

Non-device Clinical Decision Support Software Segment by Application

Drug Allergy Alerts

Drug Reminders

Drug-drug Interactions

Clinical

Non-device Clinical Decision Support Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-device Clinical Decision Support Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-device Clinical Decision Support Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-device Clinical Decision Support Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Non-device Clinical Decision Support Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Non-device Clinical Decision Support Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-device Clinical Decision Support Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-device Clinical Decision Support Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-premises Major Player Table 3. Cloud Major Player Table 4. Global Non-device Clinical Decision Support Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Drug Allergy Alerts Major Player Table 6. Drug Reminders Major Player Table 7. Drug-drug Interactions Major Player Table 8. Clinical Major Player Table 9. Non-device Clinical Decision Support Software Industry Trends Table 10. Non-device Clinical Decision Support Software Industry Drivers Table 11. Non-device Clinical Decision Support Software Industry Opportunities and Challenges Table 12. Non-device Clinical Decision Support Software Industry Restraints Table 13. Global Non-device Clinical Decision Support Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Non-device Clinical Decision Support Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Non-device Clinical Decision Support Software Market Share by Region (2021-2026) Table 16. Global Non-device Clinical Decision Support Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Non-device Clinical Decision Support Software Market Share by Region (2027-2032) Table 18. Global Non-device Clinical Decision Support Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Non-device Clinical Decision Support Software Revenue Market Share by Players (2021-2026) Table 20. Global Non-device Clinical Decision Support Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Non-device Clinical Decision Support Software Key Players Headquarters & Area Served Table 22. Global Non-device Clinical Decision Support Software Players, Product Type & Application Table 23. Global Non-device Clinical Decision Support Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Non-device Clinical Decision Support Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Non-device Clinical Decision Support Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Non-device Clinical Decision Support Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Non-device Clinical Decision Support Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Non-device Clinical Decision Support Software Revenue Market Share by Type (2021-2026) Table 30. Global Non-device Clinical Decision Support Software Revenue Market Share by Type (2027-2032) Table 31. Global Non-device Clinical Decision Support Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Non-device Clinical Decision Support Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Non-device Clinical Decision Support Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Non-device Clinical Decision Support Software Revenue Market Share by Application (2021-2026) Table 35. Global Non-device Clinical Decision Support Software Revenue Market Share by Application (2027-2032) Table 36. Roche Company Information Table 37. Roche Business Overview Table 38. Roche Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Roche Non-device Clinical Decision Support Software Product Portfolio Table 40. Roche Recent Development Table 41. Claricode Company Information Table 42. Claricode Business Overview Table 43. Claricode Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Claricode Non-device Clinical Decision Support Software Product Portfolio Table 45. Claricode Recent Development Table 46. Philips Healthcare Company Information Table 47. Philips Healthcare Business Overview Table 48. Philips Healthcare Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Philips Healthcare Non-device Clinical Decision Support Software Product Portfolio Table 50. Philips Healthcare Recent Development Table 51. Persivia Company Information Table 52. Persivia Business Overview Table 53. Persivia Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Persivia Non-device Clinical Decision Support Software Product Portfolio Table 55. Persivia Recent Development Table 56. Cerner Company Information Table 57. Cerner Business Overview Table 58. Cerner Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Cerner Non-device Clinical Decision Support Software Product Portfolio Table 60. Cerner Recent Development Table 61. Zynx Health Company Information Table 62. Zynx Health Business Overview Table 63. Zynx Health Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Zynx Health Non-device Clinical Decision Support Software Product Portfolio Table 65. Zynx Health Recent Development Table 66. Elsevier Company Information Table 67. Elsevier Business Overview Table 68. Elsevier Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Elsevier Non-device Clinical Decision Support Software Product Portfolio Table 70. Elsevier Recent Development Table 71. Epic Company Information Table 72. Epic Business Overview Table 73. Epic Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Epic Non-device Clinical Decision Support Software Product Portfolio Table 75. Epic Recent Development Table 76. EPSi/Allscripts Company Information Table 77. EPSi/Allscripts Business Overview Table 78. EPSi/Allscripts Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. EPSi/Allscripts Non-device Clinical Decision Support Software Product Portfolio Table 80. EPSi/Allscripts Recent Development Table 81. Stanson Health Company Information Table 82. Stanson Health Business Overview Table 83. Stanson Health Non-device Clinical Decision Support Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Stanson Health Non-device Clinical Decision Support Software Product Portfolio Table 85. Stanson Health Recent Development Table 86. Cambio Company Information Table 87. Cambio Business Overview Table 88. Cambio Non-device Clinical Decision Support Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Cambio Non-device Clinical Decision Support Software Product Portfolio Table 90. Cambio Recent Development Table 91. Premier Company Information Table 92. Premier Business Overview Table 93. Premier Non-device Clinical Decision Support Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Premier Non-device Clinical Decision Support Software Product Portfolio Table 95. Premier Recent Development Table 96. Truven/IBM Company Information Table 97. Truven/IBM Business Overview Table 98. Truven/IBM Non-device Clinical Decision Support Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Truven/IBM Non-device Clinical Decision Support Software Product Portfolio Table 100. Truven/IBM Recent Development Table 101. NDSC/Change Company Information Table 102. NDSC/Change Business Overview Table 103. NDSC/Change Non-device Clinical Decision Support Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. NDSC/Change Non-device Clinical Decision Support Software Product Portfolio Table 105. NDSC/Change Recent Development Table 106. MEDITECH Company Information Table 107. MEDITECH Business Overview Table 108. MEDITECH Non-device Clinical Decision Support Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. MEDITECH Non-device Clinical Decision Support Software Product Portfolio Table 110. MEDITECH Recent Development Table 111. North America Non-device Clinical Decision Support Software Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Non-device Clinical Decision Support Software Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Non-device Clinical Decision Support Software Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Non-device Clinical Decision Support Software Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Non-device Clinical Decision Support Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Non-device Clinical Decision Support Software Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Non-device Clinical Decision Support Software Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Non-device Clinical Decision Support Software Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Non-device Clinical Decision Support Software Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Non-device Clinical Decision Support Software Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Non-device Clinical Decision Support Software Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Non-device Clinical Decision Support Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Non-device Clinical Decision Support Software Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Non-device Clinical Decision Support Software Revenue by Country (US$ Million) & (2027-2032) Table 125. China Non-device Clinical Decision Support Software Revenue by Type (2021-2026) & (US$ Million) Table 126. China Non-device Clinical Decision Support Software Revenue by Type (2027-2032) & (US$ Million) Table 127. China Non-device Clinical Decision Support Software Revenue by Application (2021-2026) & (US$ Million) Table 128. China Non-device Clinical Decision Support Software Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Non-device Clinical Decision Support Software Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Non-device Clinical Decision Support Software Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Non-device Clinical Decision Support Software Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Non-device Clinical Decision Support Software Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Non-device Clinical Decision Support Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Non-device Clinical Decision Support Software Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Non-device Clinical Decision Support Software Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Non-device Clinical Decision Support Software Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Non-device Clinical Decision Support Software Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Non-device Clinical Decision Support Software Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Non-device Clinical Decision Support Software Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Non-device Clinical Decision Support Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Non-device Clinical Decision Support Software Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Non-device Clinical Decision Support Software Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Non-device Clinical Decision Support Software Image Figure 2. Global Non-device Clinical Decision Support Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-device Clinical Decision Support Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-premises Image Figure 5. Cloud Image Figure 6. Global Non-device Clinical Decision Support Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Non-device Clinical Decision Support Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Drug Allergy Alerts Image Figure 9. Drug Reminders Image Figure 10. Drug-drug Interactions Image Figure 11. Clinical Image Figure 12. Global Non-device Clinical Decision Support Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Non-device Clinical Decision Support Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Non-device Clinical Decision Support Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Non-device Clinical Decision Support Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Non-device Clinical Decision Support Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Non-device Clinical Decision Support Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Non-device Clinical Decision Support Software Revenue Market Share by Type (2021-2032) Figure 20. Global Non-device Clinical Decision Support Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Non-device Clinical Decision Support Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Non-device Clinical Decision Support Software Revenue Market Share by Application (2021-2032) Figure 23. North America Non-device Clinical Decision Support Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032) Figure 25. North America Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032) Figure 26. North America Non-device Clinical Decision Support Software Revenue Share by Country (2021-2032) Figure 27. United States Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Non-device Clinical Decision Support Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032) Figure 32. Europe Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032) Figure 33. Europe Non-device Clinical Decision Support Software Revenue Share by Country (2021-2032) Figure 34. Germany Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Non-device Clinical Decision Support Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032) Figure 44. China Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032) Figure 45. Asia Non-device Clinical Decision Support Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032) Figure 47. Asia Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032) Figure 48. Asia Non-device Clinical Decision Support Software Revenue Share by Region (2021-2032) Figure 49. Japan Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Non-device Clinical Decision Support Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Non-device Clinical Decision Support Software Revenue Share by Country (2021-2032) Figure 59. Brazil Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Non-device Clinical Decision Support Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • On-premises
  • Cloud
Applications
  • Drug Allergy Alerts
  • Drug Reminders
  • Drug-drug Interactions
  • Clinical
Companies covered
  • Roche
  • Claricode
  • Philips Healthcare
  • Persivia
  • Cerner
  • Zynx Health
  • Elsevier
  • Epic
  • EPSi/Allscripts
  • Stanson Health
  • Cambio
  • Premier
  • Truven/IBM
  • NDSC/Change
  • MEDITECH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-device Clinical Decision Support Software Market by Type
  3. 1.2.1 Global Non-device Clinical Decision Support Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-premises
  5. 1.2.3 Cloud
  6. 1.3 Non-device Clinical Decision Support Software Market by Application
  7. 1.3.1 Global Non-device Clinical Decision Support Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Drug Allergy Alerts
  9. 1.3.3 Drug Reminders
  10. 1.3.4 Drug-drug Interactions
  11. 1.3.5 Clinical
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Non-device Clinical Decision Support Software Market Dynamics
  1. 2.1 Non-device Clinical Decision Support Software Industry Trends
  2. 2.2 Non-device Clinical Decision Support Software Industry Drivers
  3. 2.3 Non-device Clinical Decision Support Software Industry Opportunities and Challenges
  4. 2.4 Non-device Clinical Decision Support Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Non-device Clinical Decision Support Software Market Perspective (2021-2032)
  2. 3.2 Global Non-device Clinical Decision Support Software Growth Trends by Region
  3. 3.2.1 Global Non-device Clinical Decision Support Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-device Clinical Decision Support Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Non-device Clinical Decision Support Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Non-device Clinical Decision Support Software Revenue by Players
  2. 4.1.1 Global Non-device Clinical Decision Support Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Non-device Clinical Decision Support Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Non-device Clinical Decision Support Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-device Clinical Decision Support Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Non-device Clinical Decision Support Software Key Players Headquarters & Area Served
  7. 4.4 Global Non-device Clinical Decision Support Software Players, Product Type & Application
  8. 4.5 Global Non-device Clinical Decision Support Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Non-device Clinical Decision Support Software Market CR5 and HHI
  11. 4.6.3 2025 Non-device Clinical Decision Support Software Tier 1, Tier 2, and Tier 3
5 Non-device Clinical Decision Support Software Market Size by Type
  1. 5.1 Global Non-device Clinical Decision Support Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Non-device Clinical Decision Support Software Revenue by Type (2021-2032)
  3. 5.3 Global Non-device Clinical Decision Support Software Revenue Market Share by Type (2021-2032)
6 Non-device Clinical Decision Support Software Market Size by Application
  1. 6.1 Global Non-device Clinical Decision Support Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Non-device Clinical Decision Support Software Revenue by Application (2021-2032)
  3. 6.3 Global Non-device Clinical Decision Support Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche Non-device Clinical Decision Support Software Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Claricode
  8. 7.2.1 Claricode Company Information
  9. 7.2.2 Claricode Business Overview
  10. 7.2.3 Claricode Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Claricode Non-device Clinical Decision Support Software Product Portfolio
  12. 7.2.5 Claricode Recent Developments
  13. 7.3 Philips Healthcare
  14. 7.3.1 Philips Healthcare Company Information
  15. 7.3.2 Philips Healthcare Business Overview
  16. 7.3.3 Philips Healthcare Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Philips Healthcare Non-device Clinical Decision Support Software Product Portfolio
  18. 7.3.5 Philips Healthcare Recent Developments
  19. 7.4 Persivia
  20. 7.4.1 Persivia Company Information
  21. 7.4.2 Persivia Business Overview
  22. 7.4.3 Persivia Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Persivia Non-device Clinical Decision Support Software Product Portfolio
  24. 7.4.5 Persivia Recent Developments
  25. 7.5 Cerner
  26. 7.5.1 Cerner Company Information
  27. 7.5.2 Cerner Business Overview
  28. 7.5.3 Cerner Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cerner Non-device Clinical Decision Support Software Product Portfolio
  30. 7.5.5 Cerner Recent Developments
  31. 7.6 Zynx Health
  32. 7.6.1 Zynx Health Company Information
  33. 7.6.2 Zynx Health Business Overview
  34. 7.6.3 Zynx Health Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Zynx Health Non-device Clinical Decision Support Software Product Portfolio
  36. 7.6.5 Zynx Health Recent Developments
  37. 7.7 Elsevier
  38. 7.7.1 Elsevier Company Information
  39. 7.7.2 Elsevier Business Overview
  40. 7.7.3 Elsevier Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Elsevier Non-device Clinical Decision Support Software Product Portfolio
  42. 7.7.5 Elsevier Recent Developments
  43. 7.8 Epic
  44. 7.8.1 Epic Company Information
  45. 7.8.2 Epic Business Overview
  46. 7.8.3 Epic Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Epic Non-device Clinical Decision Support Software Product Portfolio
  48. 7.8.5 Epic Recent Developments
  49. 7.9 EPSi/Allscripts
  50. 7.9.1 EPSi/Allscripts Company Information
  51. 7.9.2 EPSi/Allscripts Business Overview
  52. 7.9.3 EPSi/Allscripts Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 EPSi/Allscripts Non-device Clinical Decision Support Software Product Portfolio
  54. 7.9.5 EPSi/Allscripts Recent Developments
  55. 7.10 Stanson Health
  56. 7.10.1 Stanson Health Company Information
  57. 7.10.2 Stanson Health Business Overview
  58. 7.10.3 Stanson Health Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Stanson Health Non-device Clinical Decision Support Software Product Portfolio
  60. 7.10.5 Stanson Health Recent Developments
  61. 7.11 Cambio
  62. 7.11.1 Cambio Company Information
  63. 7.11.2 Cambio Business Overview
  64. 7.11.3 Cambio Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cambio Non-device Clinical Decision Support Software Product Portfolio
  66. 7.11.5 Cambio Recent Developments
  67. 7.12 Premier
  68. 7.12.1 Premier Company Information
  69. 7.12.2 Premier Business Overview
  70. 7.12.3 Premier Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Premier Non-device Clinical Decision Support Software Product Portfolio
  72. 7.12.5 Premier Recent Developments
  73. 7.13 Truven/IBM
  74. 7.13.1 Truven/IBM Company Information
  75. 7.13.2 Truven/IBM Business Overview
  76. 7.13.3 Truven/IBM Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Truven/IBM Non-device Clinical Decision Support Software Product Portfolio
  78. 7.13.5 Truven/IBM Recent Developments
  79. 7.14 NDSC/Change
  80. 7.14.1 NDSC/Change Company Information
  81. 7.14.2 NDSC/Change Business Overview
  82. 7.14.3 NDSC/Change Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 NDSC/Change Non-device Clinical Decision Support Software Product Portfolio
  84. 7.14.5 NDSC/Change Recent Developments
  85. 7.15 MEDITECH
  86. 7.15.1 MEDITECH Company Information
  87. 7.15.2 MEDITECH Business Overview
  88. 7.15.3 MEDITECH Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 MEDITECH Non-device Clinical Decision Support Software Product Portfolio
  90. 7.15.5 MEDITECH Recent Developments
8 North America
  1. 8.1 North America Non-device Clinical Decision Support Software Revenue (2021-2032)
  2. 8.2 North America Non-device Clinical Decision Support Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Non-device Clinical Decision Support Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Non-device Clinical Decision Support Software Revenue by Type (2027-2032)
  5. 8.3 North America Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Non-device Clinical Decision Support Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Non-device Clinical Decision Support Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Non-device Clinical Decision Support Software Revenue by Application (2027-2032)
  9. 8.5 North America Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Non-device Clinical Decision Support Software Revenue by Country
  11. 8.6.1 North America Non-device Clinical Decision Support Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Non-device Clinical Decision Support Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Non-device Clinical Decision Support Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Non-device Clinical Decision Support Software Revenue (2021-2032)
  2. 9.2 Europe Non-device Clinical Decision Support Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Non-device Clinical Decision Support Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Non-device Clinical Decision Support Software Revenue by Type (2027-2032)
  5. 9.3 Europe Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Non-device Clinical Decision Support Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Non-device Clinical Decision Support Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Non-device Clinical Decision Support Software Revenue by Application (2027-2032)
  9. 9.5 Europe Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Non-device Clinical Decision Support Software Revenue by Country
  11. 9.6.1 Europe Non-device Clinical Decision Support Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Non-device Clinical Decision Support Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Non-device Clinical Decision Support Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Non-device Clinical Decision Support Software Revenue (2021-2032)
  2. 10.2 China Non-device Clinical Decision Support Software Revenue by Type (2021-2032)
  3. 10.2.1 China Non-device Clinical Decision Support Software Revenue by Type (2021-2026)
  4. 10.2.2 China Non-device Clinical Decision Support Software Revenue by Type (2027-2032)
  5. 10.3 China Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032)
  6. 10.4 China Non-device Clinical Decision Support Software Revenue by Application (2021-2032)
  7. 10.4.1 China Non-device Clinical Decision Support Software Revenue by Application (2021-2026)
  8. 10.4.2 China Non-device Clinical Decision Support Software Revenue by Application (2027-2032)
  9. 10.5 China Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-device Clinical Decision Support Software Revenue (2021-2032)
  2. 11.2 Asia Non-device Clinical Decision Support Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Non-device Clinical Decision Support Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Non-device Clinical Decision Support Software Revenue by Type (2027-2032)
  5. 11.3 Asia Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Non-device Clinical Decision Support Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Non-device Clinical Decision Support Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Non-device Clinical Decision Support Software Revenue by Application (2027-2032)
  9. 11.5 Asia Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Non-device Clinical Decision Support Software Revenue by Country
  11. 11.6.1 Asia Non-device Clinical Decision Support Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Non-device Clinical Decision Support Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Non-device Clinical Decision Support Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-device Clinical Decision Support Software Revenue (2021-2032)
  2. 12.2 SAMEA Non-device Clinical Decision Support Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Non-device Clinical Decision Support Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Non-device Clinical Decision Support Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Non-device Clinical Decision Support Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Non-device Clinical Decision Support Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Non-device Clinical Decision Support Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Non-device Clinical Decision Support Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Non-device Clinical Decision Support Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Non-device Clinical Decision Support Software Revenue by Country
  11. 12.6.1 SAMEA Non-device Clinical Decision Support Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Non-device Clinical Decision Support Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Non-device Clinical Decision Support Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst